nodes	percent_of_prediction	percent_of_DWPC	metapath
Omeprazole—CYP11A1—Metabolism of steroid hormones and vitamin D—CGA—conduct disorder	0.0966	0.0966	CbGpPWpGaD
Omeprazole—ATP4B—Ion channel transport—GABRA2—conduct disorder	0.0708	0.0708	CbGpPWpGaD
Omeprazole—ATP4A—Ion channel transport—GABRA2—conduct disorder	0.0631	0.0631	CbGpPWpGaD
Omeprazole—CYP1B1—Estrogen metabolism—COMT—conduct disorder	0.0452	0.0452	CbGpPWpGaD
Omeprazole—CYP1B1—Melatonin metabolism and effects—MAOA—conduct disorder	0.0306	0.0306	CbGpPWpGaD
Omeprazole—CYP1A2—Methylation—COMT—conduct disorder	0.0284	0.0284	CbGpPWpGaD
Omeprazole—CYP1A1—Estrogen metabolism—COMT—conduct disorder	0.0278	0.0278	CbGpPWpGaD
Omeprazole—ATP4B—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.0246	0.0246	CbGpPWpGaD
Omeprazole—ATP4A—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.022	0.022	CbGpPWpGaD
Omeprazole—CYP11A1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0218	0.0218	CbGpPWpGaD
Omeprazole—CYP1A1—Melatonin metabolism and effects—MAOA—conduct disorder	0.0189	0.0189	CbGpPWpGaD
Omeprazole—CYP2C18—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0188	0.0188	CbGpPWpGaD
Omeprazole—CYP1A1—Oxidative Stress—MAOA—conduct disorder	0.0184	0.0184	CbGpPWpGaD
Omeprazole—CYP1A2—Estrogen metabolism—COMT—conduct disorder	0.0177	0.0177	CbGpPWpGaD
Omeprazole—CYP2C19—Melatonin metabolism and effects—MAOA—conduct disorder	0.0154	0.0154	CbGpPWpGaD
Omeprazole—ABCC3—NRF2 pathway—SLC6A4—conduct disorder	0.0147	0.0147	CbGpPWpGaD
Omeprazole—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.0142	0.0142	CbGpPWpGaD
Omeprazole—CYP1B1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0139	0.0139	CbGpPWpGaD
Omeprazole—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.0137	0.0137	CbGpPWpGaD
Omeprazole—CYP2C18—FOXA1 transcription factor network—EP300—conduct disorder	0.0129	0.0129	CbGpPWpGaD
Omeprazole—CYP1A2—Melatonin metabolism and effects—MAOA—conduct disorder	0.012	0.012	CbGpPWpGaD
Omeprazole—CYP11A1—Biological oxidations—COMT—conduct disorder	0.0116	0.0116	CbGpPWpGaD
Omeprazole—CYP11A1—Biological oxidations—MAOA—conduct disorder	0.0116	0.0116	CbGpPWpGaD
Omeprazole—CYP11A1—Metapathway biotransformation—COMT—conduct disorder	0.0115	0.0115	CbGpPWpGaD
Omeprazole—ABCG2—HIF-2-alpha transcription factor network—EP300—conduct disorder	0.0106	0.0106	CbGpPWpGaD
Omeprazole—CYP2C18—Biological oxidations—COMT—conduct disorder	0.0101	0.0101	CbGpPWpGaD
Omeprazole—CYP2C18—Biological oxidations—MAOA—conduct disorder	0.01	0.01	CbGpPWpGaD
Omeprazole—CYP2C18—Metapathway biotransformation—COMT—conduct disorder	0.00993	0.00993	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.0099	0.0099	CbGpPWpGaD
Omeprazole—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00914	0.00914	CbGpPWpGaD
Omeprazole—CYP1B1—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00914	0.00914	CbGpPWpGaD
Omeprazole—CYP1A1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00855	0.00855	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00833	0.00833	CbGpPWpGaD
Omeprazole—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00784	0.00784	CbGpPWpGaD
Omeprazole—ABCC3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00743	0.00743	CbGpPWpGaD
Omeprazole—CYP1B1—Biological oxidations—COMT—conduct disorder	0.00742	0.00742	CbGpPWpGaD
Omeprazole—CYP1B1—Biological oxidations—MAOA—conduct disorder	0.00737	0.00737	CbGpPWpGaD
Omeprazole—CYP1B1—Metapathway biotransformation—COMT—conduct disorder	0.00732	0.00732	CbGpPWpGaD
Omeprazole—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00699	0.00699	CbGpPWpGaD
Omeprazole—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00643	0.00643	CbGpPWpGaD
Omeprazole—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00638	0.00638	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00632	0.00632	CbGpPWpGaD
Omeprazole—ABCG2—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00623	0.00623	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00563	0.00563	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00563	0.00563	CbGpPWpGaD
Omeprazole—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00545	0.00545	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00512	0.00512	CbGpPWpGaD
Omeprazole—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.00498	0.00498	CbGpPWpGaD
Omeprazole—CYP1A1—Biological oxidations—COMT—conduct disorder	0.00457	0.00457	CbGpPWpGaD
Omeprazole—CYP1A1—Biological oxidations—MAOA—conduct disorder	0.00454	0.00454	CbGpPWpGaD
Omeprazole—CYP1A1—Metapathway biotransformation—COMT—conduct disorder	0.00451	0.00451	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—CGA—conduct disorder	0.00441	0.00441	CbGpPWpGaD
Omeprazole—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00421	0.00421	CbGpPWpGaD
Omeprazole—CYP2C8—Biological oxidations—COMT—conduct disorder	0.00419	0.00419	CbGpPWpGaD
Omeprazole—CYP2C8—Biological oxidations—MAOA—conduct disorder	0.00416	0.00416	CbGpPWpGaD
Omeprazole—CYP2C8—Metapathway biotransformation—COMT—conduct disorder	0.00413	0.00413	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00389	0.00389	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—CGA—conduct disorder	0.00382	0.00382	CbGpPWpGaD
Omeprazole—CYP2C19—Biological oxidations—COMT—conduct disorder	0.00374	0.00374	CbGpPWpGaD
Omeprazole—CYP2C19—Biological oxidations—MAOA—conduct disorder	0.00372	0.00372	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—CGA—conduct disorder	0.00371	0.00371	CbGpPWpGaD
Omeprazole—CYP2C19—Metapathway biotransformation—COMT—conduct disorder	0.00369	0.00369	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00359	0.00359	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00359	0.00359	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00357	0.00357	CbGpPWpGaD
Omeprazole—CYP2D6—Biological oxidations—COMT—conduct disorder	0.00344	0.00344	CbGpPWpGaD
Omeprazole—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.00342	0.00342	CbGpPWpGaD
Omeprazole—CYP2C9—Biological oxidations—COMT—conduct disorder	0.00341	0.00341	CbGpPWpGaD
Omeprazole—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.00339	0.00339	CbGpPWpGaD
Omeprazole—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.00339	0.00339	CbGpPWpGaD
Omeprazole—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00337	0.00337	CbGpPWpGaD
Omeprazole—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.00336	0.00336	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00318	0.00318	CbGpPWpGaD
Omeprazole—CYP1A2—Biological oxidations—COMT—conduct disorder	0.00292	0.00292	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.0029	0.0029	CbGpPWpGaD
Omeprazole—CYP1A2—Biological oxidations—MAOA—conduct disorder	0.00289	0.00289	CbGpPWpGaD
Omeprazole—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	0.00288	0.00288	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—CGA—conduct disorder	0.00281	0.00281	CbGpPWpGaD
Omeprazole—CYP1A1—PPARA activates gene expression—EP300—conduct disorder	0.0028	0.0028	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00277	0.00277	CbGpPWpGaD
Omeprazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	0.00274	0.00274	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—CGA—conduct disorder	0.00256	0.00256	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00248	0.00248	CbGpPWpGaD
Omeprazole—CYP3A4—Biological oxidations—COMT—conduct disorder	0.00225	0.00225	CbGpPWpGaD
Omeprazole—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.00223	0.00223	CbGpPWpGaD
Omeprazole—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.00222	0.00222	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—COMT—conduct disorder	0.00199	0.00199	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—MAOA—conduct disorder	0.00198	0.00198	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00192	0.00192	CbGpPWpGaD
Omeprazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.00189	0.00189	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CGA—conduct disorder	0.00173	0.00173	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—COMT—conduct disorder	0.00172	0.00172	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—MAOA—conduct disorder	0.00171	0.00171	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—COMT—conduct disorder	0.00168	0.00168	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—MAOA—conduct disorder	0.00166	0.00166	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00161	0.00161	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CGA—conduct disorder	0.00159	0.00159	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00144	0.00144	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CGA—conduct disorder	0.00142	0.00142	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CGA—conduct disorder	0.00138	0.00138	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CGA—conduct disorder	0.0013	0.0013	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CGA—conduct disorder	0.00129	0.00129	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—COMT—conduct disorder	0.00127	0.00127	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—MAOA—conduct disorder	0.00126	0.00126	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00122	0.00122	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—COMT—conduct disorder	0.00116	0.00116	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—MAOA—conduct disorder	0.00115	0.00115	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CGA—conduct disorder	0.0011	0.0011	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—EP300—conduct disorder	0.000854	0.000854	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CGA—conduct disorder	0.000852	0.000852	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—COMT—conduct disorder	0.000782	0.000782	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—MAOA—conduct disorder	0.000776	0.000776	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000753	0.000753	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—EP300—conduct disorder	0.000739	0.000739	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—EP300—conduct disorder	0.000718	0.000718	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—COMT—conduct disorder	0.000717	0.000717	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—MAOA—conduct disorder	0.000712	0.000712	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00069	0.00069	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—COMT—conduct disorder	0.00064	0.00064	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—MAOA—conduct disorder	0.000635	0.000635	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—COMT—conduct disorder	0.000625	0.000625	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—MAOA—conduct disorder	0.00062	0.00062	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000616	0.000616	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—COMT—conduct disorder	0.000588	0.000588	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—MAOA—conduct disorder	0.000584	0.000584	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—COMT—conduct disorder	0.000583	0.000583	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—MAOA—conduct disorder	0.000579	0.000579	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000562	0.000562	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—EP300—conduct disorder	0.000544	0.000544	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—COMT—conduct disorder	0.000499	0.000499	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—EP300—conduct disorder	0.000495	0.000495	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—MAOA—conduct disorder	0.000495	0.000495	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00048	0.00048	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—COMT—conduct disorder	0.000385	0.000385	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—MAOA—conduct disorder	0.000382	0.000382	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—EP300—conduct disorder	0.000335	0.000335	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—EP300—conduct disorder	0.000307	0.000307	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—EP300—conduct disorder	0.000274	0.000274	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—EP300—conduct disorder	0.000268	0.000268	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—EP300—conduct disorder	0.000252	0.000252	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—EP300—conduct disorder	0.00025	0.00025	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—EP300—conduct disorder	0.000214	0.000214	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—EP300—conduct disorder	0.000165	0.000165	CbGpPWpGaD
